Delivered revenues of $78.7 million and operating cash flow of
$5.6 million
New PyroThin
award with leading American OEM for next-gen prismatic LFP vehicle
platform
NORTHBOROUGH, Mass., May 8, 2025
/PRNewswire/ -- Aspen Aerogels, Inc. (NYSE: ASPN) ("Aspen" or the "Company"), a technology leader
in sustainability and electrification solutions, today announced
financial results for the first quarter of 2025, and discussed
recent business developments.
Total revenue for the first quarter of 2025 was $78.7 million, compared to $94.5 million in the first quarter of 2024.
Net loss was $301.2 million, which
included a $286.6 million impairment
charge in connection with the demobilization of the Company's
previously planned second aerogel manufacturing plant in
Statesboro, Georgia and
$9.8 million of associated
restructuring costs, compared to a net loss of $1.8 million in the first quarter of 2024.
Adjusting net loss for the impairment and restructuring and
demobilization costs would result in a net loss of $4.8 million. Net loss per share was $3.67, compared to a net loss per share of
$0.02 in the first quarter of 2024.
Adjusting net loss per share for the impairment and restructuring
and demobilization costs would result in a net loss per share of
$0.06.
Adjusted EBITDA for the first quarter of 2025 was $4.9 million, compared to $12.9 million in the first quarter of 2024.
A reconciliation of GAAP financial results to non-GAAP financial
results are provided in the financial schedules that are part of
this press release. An explanation of these non-GAAP financial
measures are also included below under the heading "Non-GAAP
Financial Measures."
Recent Business Highlights & Quarterly
Performance
- Company revenues of $78.7
million, a 17% decrease year-over-year (YoY)
- Thermal Barrier: $48.9
million of revenue, a 25% decrease YoY
- Energy Industrial: $29.8
million of revenue, a 3% increase YoY
- Delivered gross margins of 29%, an eight-percentage point
decrease YoY
- Operating cash flow of $5.6
million in the quarter
- Ended the quarter with cash and equivalents of $192.0 million
- Awarded PyroThin contract from a leading American OEM for a
next-gen prismatic lithium iron phosphate (LFP) vehicle platform
with an expected start of production in 2028
"We continue to drive the key elements of our strategy by
broadening our Thermal Barrier and Energy Industrial commercial
activities, fortifying our supply chain, and optimizing our cost
structure," commented Don Young,
Aspen's President and CEO. "We are
encouraged by the record-level quoting activity in our PyroThin
thermal barrier business. The newest PyroThin award demonstrates
our value in additional electric vehicle ("EV") form factors and
chemistries. Meanwhile, our Energy Industrial segment is now
equipped with the supply needed to pursue additional geographies
and end markets to drive incremental growth. A diversified supply
chain and multiple aerogel manufacturing sources provide us with
the flexibility to optimally meet customer demands across both
business segments. Our recent and continuing actions to reduce
fixed costs are an example of an ongoing focus on our financial
performance and strong balance sheet."
Q2 2025 Financial Outlook
Aspen's Q2 2025 Outlook is as follows:
- Revenue is expected to range between $70 and $80
million
- Net loss is expected to range between $11 and $4
million
- Net loss per share is expected to range between $0.13 and $0.05
- Adjusted EBITDA is expected to range between breakeven and
$7 million
- Capital Expenditures, excluding demobilization costs related to
the Statesboro plant project, are
expected to be less than $10
million
Ricardo C. Rodriguez, Chief
Financial Officer and Treasurer, noted, "We have the right elements
in place to focus on execution and drive performance through a
broad range of demand outcomes. A strong balance sheet and
continuing efforts to reduce our fixed cost base will ensure that
we are not only better positioned for profitability and cash flow
generation but can also deliver higher proportional upside as the
outlook clears up."
The Company's Q2 2025 outlook assumes depreciation and
amortization of $6.0 million,
stock-based compensation expense of $3.0
million, other expense (net) of $2.0
million, and diluted weighted average shares outstanding of
82.0 million for the full year.
A reconciliation of net loss to non-GAAP Adjusted EBITDA for the
Q2 2025 financial outlook is provided in the financial schedules
that are part of this press release. An explanation of this
non-GAAP financial measure is also included below under the heading
"Non-GAAP Financial Measures."
Aspen may incur, among other
items, additional charges, realize gains or losses, incur financing
costs or interest expense, or experience other events in Q2 2025,
including those related to the planned capacity expansion, supply
chain disruptions, or further cost inflation, that could cause
actual results to vary materially from this outlook. See Special
Note Regarding Forward-Looking and Cautionary Statements below.
Conference Call and Webcast Notification
A conference
call with Aspen management to
discuss first quarter 2025 results and recent business developments
will be held Thursday, May 8, 2025 at
8:30 a.m. EST. During the call,
management will respond to questions concerning, but not limited
to, Aspen's financial performance,
business conditions, and financial outlook. Management's discussion
and responses could contain information that has not been
previously disclosed.
Shareholders and other interested parties may call +1 (404)
975-4839 (domestic) or +1 (929) 526-1599 (international) and
reference conference ID "302641" to participate in the conference
call. In addition, the conference call and an accompanying slide
presentation will be available live as a listen-only webcast hosted
at the Investors section of Aspen's website, www.aerogel.com.
Following the live event, an archived version of the webcast
will be available on Aspen's
website for convenient on-demand replay for at least a year. A copy
of this press release is posted in the Investors section on
Aspen's website.
Non-GAAP Financial Measures
In addition to providing
financial measurements based on generally accepted accounting
principles in the United States of
America ("GAAP"), Aspen
provides additional financial metrics that are not prepared in
accordance with GAAP ("non-GAAP"). The non-GAAP financial measures
included in this press release are Adjusted EBITDA, adjusted net
loss and adjusted net loss per share. Management uses these
non-GAAP financial measures, in addition to GAAP financial
measures, as a measure of operating performance because the
non-GAAP financial measures do not include the impact of items that
management does not consider indicative of Aspen's core operating performance. In
addition, management uses Adjusted EBITDA (i) for planning
purposes, including the preparation of Aspen's annual operating budget, (ii) to
allocate resources to enhance the financial performance of its
business, and (iii) as a performance measure under its bonus
plan.
Management believes that these non-GAAP financial measures
reflect Aspen's ongoing business
in a manner that allows for meaningful comparisons and analysis of
trends in its business, as it excludes expenses and gains not
reflective of Aspen's ongoing
operating results or that may be infrequent and/or unusual in
nature. Management also believes that these non-GAAP financial
measures provides useful information to investors in understanding
and evaluating Aspen's operating
results and future prospects in the same manner as management and
in comparing financial results across accounting periods and to
those of peer companies. These non-GAAP measures may not be
comparable to similarly titled measures presented by other
companies.
The non-GAAP financial measures do not replace the presentation
of Aspen's GAAP financial results
and should only be used as a supplement to, not as a substitute
for, Aspen's financial results
presented in accordance with GAAP. In this press release,
Aspen has provided a
reconciliation of Adjusted EBITDA to net income (loss), adjusted
net loss to net loss and adjusted net loss per share to net loss
per share, in each case the most directly comparable GAAP financial
measure. Management strongly encourages investors to review
Aspen's financial statements and
publicly filed reports in their entirety and not rely on any single
financial measure.
About Aspen Aerogels, Inc.
Aspen is a technology leader in sustainability
and electrification solutions. The Company's aerogel technology
enables its customers and partners to achieve their own objectives
around the global megatrends of resource efficiency, e-mobility and
clean energy. Aspen's PyroThin®
products enable solutions to thermal runaway challenges within the
electric vehicle ("EV") market. The Company's carbon aerogel
initiative seeks to increase the performance of lithium-ion battery
cells to enable EV manufacturers to reduce charging time and the
cost of EVs. The Company's Cryogel® and Pyrogel® products are
valued by the world's largest energy infrastructure companies.
Aspen's strategy is to partner
with world-class industry leaders to leverage its Aerogel
Technology Platform® into additional high-value markets.
Aspen is headquartered in
Northborough, Mass. For more
information, please visit www.aerogel.com.
Special Note Regarding Forward-Looking and Cautionary
Statements
This press release and any related discussion
contains "forward-looking statements" within the meaning of the
Private Securities Litigation Reform Act of 1995 that involve risks
and uncertainties that could cause actual results to be materially
different from historical results or from any future results
expressed or implied by such forward-looking statements, including
statements relating to Aspen's
financial outlook for the second quarter of 2025. These statements
are not historical facts but rather are based on Aspen's current expectations, estimates and
projections regarding Aspen's
business, operations and other factors relating thereto, including
with respect to Aspen's financial
outlook for the second quarter of 2025. Words such as "may,"
"will," "could," "would," "should," "anticipate," "predict,"
"potential," "continue," "expects," "intends," "plans," "projects,"
"believes," "estimates," "outlook," "assumes," "targets,"
"opportunity," and similar expressions are used to identify these
forward-looking statements. Such forward-looking statements include
statements regarding, among other things, Aspen's beliefs and expectations about
capacity, revenue, revenue capacity, backlog, costs, expenses,
profitability, cash flow, gross profit, gross margin, operating
margin, net income (loss), Adjusted EBITDA and related increases,
decreases, trends or timing, including with respect to Aspen's beliefs and expectations about the EV
market and how it may enable a path to profitability; Aspen's target revenue capacity and gross
margins; Aspen's efforts to
demobilize its previously planned second manufacturing plant in
Statesboro, Georgia, and the use
of its external manufacturing facility to meet customer demand;
current or future trends in the energy, energy infrastructure,
chemical and refinery, LNG, sustainable building materials, EV
thermal barrier, EV battery materials or other markets and the
impact of these trends on Aspen's
business; the strength, effectiveness, productivity, costs,
profitability or other fundamentals of Aspen's business; beliefs about the role of
Aspen's technology and
opportunities in the EV market; beliefs about Aspen's ability to provide and deliver
products and services to EV customers; beliefs about content per
vehicle, revenue, costs, expenses, profitability, investments or
cash flow associated with Aspen's
EV opportunities, including the EV thermal barrier business; and
the performance and market acceptance of Aspen's products. All such forward-looking
statements are based on management's present expectations and are
subject to certain factors, risks and uncertainties that may cause
actual results, outcome of events, timing and performance to differ
materially from those expressed or implied by such statements.
These risks and uncertainties include, but are not limited to, the
following: inability to execute Aspen's growth plan, the right of EV thermal
barrier customers to cancel contracts with Aspen at any time and without penalty; any
costs, expenses, or investments incurred by Aspen in excess of projections used to develop
pricing under the contracts with EV thermal barrier customers;
Aspen's inability to create
customer or market opportunities for its products; any disruption
or inability to achieve expected capacity levels in any of its
manufacturing or assembly facilities, including at its external
manufacturing facility; any failure to enforce any of Aspen's patents; the general economic
conditions and cyclical demands in the markets that Aspen serves; the potential impact of changes
in government and economic policies, incentives, and tariffs on
Aspen's customers, production,
sales, cost structure, competitive landscape and results of
operations; and the other risk factors discussed under the heading
"Risk Factors" in Aspen's Annual
Report on Form 10-K for the year ended December 31, 2024 and filed with the Securities
and Exchange Commission ("SEC") on February
27, 2025, as well as any updates to those risk factors filed
from time to time in Aspen's
subsequent periodic and current reports filed with the SEC. All
statements contained in this press release are made only as of the
date of this press release. Aspen
does not intend to update this information unless required by
law.
ASPEN AEROGELS,
INC.
Condensed
Consolidated Balance Sheets
(Unaudited and in
thousands)
|
|
|
|
|
|
|
|
|
|
March 31,
|
|
|
December 31,
|
|
|
|
2025
|
|
|
2024
|
|
|
|
(In
thousands)
|
|
Assets
|
|
|
|
|
|
|
Current
assets:
|
|
|
|
|
|
|
Cash and cash
equivalents
|
|
$
|
192,039
|
|
|
$
|
220,882
|
|
Restricted
cash
|
|
|
394
|
|
|
|
394
|
|
Accounts receivable,
net
|
|
|
77,355
|
|
|
|
109,104
|
|
Inventories
|
|
|
56,739
|
|
|
|
47,551
|
|
Prepaid expenses and
other current assets
|
|
|
17,359
|
|
|
|
31,517
|
|
Total current
assets
|
|
|
343,886
|
|
|
|
409,448
|
|
Property, plant and
equipment, net
|
|
|
179,282
|
|
|
|
459,276
|
|
Operating lease
right-of-use assets
|
|
|
19,103
|
|
|
|
20,854
|
|
Finance lease
right-of-use assets
|
|
|
5,934
|
|
|
|
—
|
|
Other long-term
assets
|
|
|
6,771
|
|
|
|
5,566
|
|
Total
assets
|
|
$
|
554,976
|
|
|
$
|
895,144
|
|
Liabilities and
Stockholders' Equity
|
|
|
|
|
|
|
Current
liabilities:
|
|
|
|
|
|
|
Accounts
payable
|
|
$
|
39,931
|
|
|
$
|
44,361
|
|
Accrued
expenses
|
|
|
16,681
|
|
|
|
36,495
|
|
Deferred
revenue
|
|
|
2,645
|
|
|
|
2,199
|
|
Finance obligation for
sale and leaseback transactions
|
|
|
3,929
|
|
|
|
4,028
|
|
Operating lease
liabilities
|
|
|
3,339
|
|
|
|
3,279
|
|
Finance lease
liabilities
|
|
|
1,408
|
|
|
|
—
|
|
Long term debt -
current portion
|
|
|
13,500
|
|
|
|
19,750
|
|
Total current
liabilities
|
|
|
81,433
|
|
|
|
110,112
|
|
Revolving line of
credit
|
|
|
28,956
|
|
|
|
42,131
|
|
Long term
debt
|
|
|
95,416
|
|
|
|
94,961
|
|
Finance obligation for
sale and leaseback
transactions long-term
|
|
|
8,353
|
|
|
|
10,087
|
|
Operating lease
liabilities long-term
|
|
|
22,305
|
|
|
|
23,148
|
|
Finance lease
liabilities long-term
|
|
|
3,679
|
|
|
|
—
|
|
Total
liabilities
|
|
|
240,142
|
|
|
|
280,439
|
|
Stockholders'
equity:
|
|
|
|
|
|
|
Total stockholders'
equity
|
|
|
314,834
|
|
|
|
614,705
|
|
Total liabilities and
stockholders' equity
|
|
$
|
554,976
|
|
|
$
|
895,144
|
|
ASPEN AEROGELS,
INC.
Consolidated
Statements of Operations
(Unaudited and in
thousands, except share and per share data)
|
|
|
|
Three Months
Ended
|
|
|
|
March 31,
|
|
|
|
2025
|
|
|
2024
|
|
|
|
(In thousands,
except
share and per share data)
|
|
Revenue
|
|
$
|
78,723
|
|
|
$
|
94,501
|
|
Cost of
revenue
|
|
|
55,911
|
|
|
|
59,358
|
|
Gross
profit
|
|
|
22,812
|
|
|
|
35,143
|
|
Operating
expenses:
|
|
|
|
|
|
|
Research and
development
|
|
|
4,333
|
|
|
|
4,489
|
|
Sales and
marketing
|
|
|
8,384
|
|
|
|
8,303
|
|
General and
administrative
|
|
|
13,034
|
|
|
|
17,213
|
|
Restructuring and
demobilization costs
|
|
|
9,790
|
|
|
|
—
|
|
Impairment of
property, plant and equipment
|
|
|
286,612
|
|
|
|
2,702
|
|
Total operating
expenses
|
|
|
322,153
|
|
|
|
32,707
|
|
Income (loss) from
operations
|
|
|
(299,341)
|
|
|
|
2,436
|
|
Other income
(expense)
|
|
|
|
|
|
|
Interest expense,
convertible note - related party
|
|
|
—
|
|
|
|
(3,038)
|
|
Interest income
(expense)
|
|
|
(1,962)
|
|
|
|
(477)
|
|
Other
income
|
|
|
1,130
|
|
|
|
—
|
|
Total other
expense
|
|
|
(832)
|
|
|
|
(3,515)
|
|
Loss before income tax
expense
|
|
|
(300,173)
|
|
|
|
(1,079)
|
|
Income tax
expense
|
|
|
(1,076)
|
|
|
|
(756)
|
|
Net loss
|
|
$
|
(301,249)
|
|
|
$
|
(1,835)
|
|
Net loss per
share:
|
|
|
|
|
|
|
Basic and
diluted
|
|
$
|
(3.67)
|
|
|
$
|
(0.02)
|
|
Weighted-average common
shares outstanding:
|
|
|
|
|
|
|
Basic and
diluted
|
|
|
82,065,676
|
|
|
|
75,762,893
|
|
Analysis of Cash Flow
The following table summarizes our cash flows for the periods
indicated.
|
|
Three Months
Ended
|
|
|
|
March
31
|
|
|
|
2025
|
|
|
2024
|
|
|
|
(In
thousands)
|
|
Net cash provided by
(used in):
|
|
|
|
|
|
|
Operating
activities
|
|
$
|
5,632
|
|
|
$
|
(17,749)
|
|
Investing
activities
|
|
|
(12,998)
|
|
|
|
(25,863)
|
|
Financing
activities
|
|
|
(21,477)
|
|
|
|
5,259
|
|
Net decrease in
cash
|
|
|
(28,843)
|
|
|
|
(38,353)
|
|
Cash, cash equivalents
and restricted cash at beginning
of period
|
|
|
221,276
|
|
|
|
139,971
|
|
Cash, cash equivalents
and restricted cash at end of
period
|
|
$
|
192,433
|
|
|
$
|
101,618
|
|
Reconciliation of Non-GAAP Financial Measures
The following tables present a reconciliation of the non-GAAP
financial measure included in this press release to the most
directly comparable GAAP measure:
Reconciliation of Adjusted EBITDA to Net loss
We define Adjusted EBITDA as net income (loss) before interest
expense, taxes, depreciation, amortization, stock-based
compensation expense and other items, which occur from time to time
and which we do not believe are indicative of our core operating
performance.
For the three months ended March 31,
2025 and 2024:
|
|
Three Months
Ended
|
|
|
|
March 31,
|
|
|
|
2025
|
|
|
2024
|
|
|
|
(In
thousands)
|
|
Net loss
|
|
$
|
(301,249)
|
|
|
$
|
(1,835)
|
|
Depreciation and
amortization
|
|
|
5,793
|
|
|
|
5,786
|
|
Stock-based
compensation
|
|
|
2,073
|
|
|
|
4,706
|
|
Other
expense
|
|
|
832
|
|
|
|
3,515
|
|
Income tax
expense
|
|
|
1,076
|
|
|
|
756
|
|
Restructuring and
demobilization costs
|
|
|
9,790
|
|
|
|
-
|
|
Impairment of
property, plant and equipment
|
|
|
286,612
|
|
|
|
-
|
|
Adjusted
EBITDA
|
|
$
|
4,927
|
|
|
$
|
12,928
|
|
For the trailing twelve months ended March 31, 2025 and 2024:
|
|
Last Twelve
Months
|
|
|
|
March 31,
|
|
|
|
2025
|
|
|
2024
|
|
|
|
(In
thousands)
|
|
Net loss
|
|
$
|
(286,039)
|
|
|
$
|
(30,850)
|
|
Depreciation and
amortization
|
|
|
22,533
|
|
|
|
18,400
|
|
Stock-based
compensation
|
|
|
10,222
|
|
|
|
13,393
|
|
Other
expense
|
|
|
9,276
|
|
|
|
2,235
|
|
Loss on extinguishment
of debt
|
|
|
27,487
|
|
|
|
-
|
|
Income tax
expense
|
|
|
2,034
|
|
|
|
756
|
|
Restructuring and
demobilization costs
|
|
|
9,790
|
|
|
|
-
|
|
Impairment of
property, plant and equipment
|
|
|
286,612
|
|
|
|
-
|
|
Adjusted
EBITDA
|
|
$
|
81,915
|
|
|
$
|
3,934
|
|
Other Information
The following table reconciles net loss and net loss per share
to adjusted net loss and adjusted net loss per share for the three
months ended March 31, 2025 and
2024:
|
|
Three Months
Ended
|
|
|
|
March 31,
2025
|
|
|
March 31,
2024
|
|
|
|
Amount
|
|
|
Per
Share
|
|
|
Amount
|
|
|
Per
Share
|
|
|
|
(In
thousands)
|
|
|
|
|
|
(In
thousands)
|
|
|
|
|
Net loss
|
|
$
|
(301,249)
|
|
|
$
|
(3.67)
|
|
|
$
|
(1,835)
|
|
|
$
|
(0.02)
|
|
Restructuring and
demobilization costs
|
|
|
9,790
|
|
|
|
0.12
|
|
|
|
—
|
|
|
|
-
|
|
Impairment of
property, plant and equipment
|
|
|
286,612
|
|
|
|
3.49
|
|
|
|
—
|
|
|
|
-
|
|
Adjusted Net
Loss
|
|
$
|
(4,847)
|
|
|
$
|
(0.06)
|
|
|
$
|
(1,835)
|
|
|
$
|
(0.02)
|
|
Financial outlook for the three months ending June 30, 2025:
|
|
Three Months
Ending
|
|
|
|
June 30,
2025
|
|
|
|
Low
|
|
|
High
|
|
|
|
(In
thousands)
|
|
Net loss
|
|
$
|
(11,000)
|
|
|
$
|
(4,000)
|
|
Depreciation and
amortization
|
|
|
6,000
|
|
|
|
6,000
|
|
Stock-based
compensation
|
|
|
3,000
|
|
|
|
3,000
|
|
Other expense,
net
|
|
|
2,000
|
|
|
|
2,000
|
|
Adjusted
EBITDA
|
|
$
|
—
|
|
|
$
|
7,000
|
|
View original
content:https://www.prnewswire.com/news-releases/aspen-aerogels-inc-reports-first-quarter-2025-financial-results-and-recent-business-highlights-302449529.html
SOURCE Aspen Aerogels, Inc.